TiGenix gains CE mark for ChondroCelect, an ACI treatment for cartilage regeneration, plans launches in in Germany, the Netherlands, United Kingdom and Belgium
What differentiates ChondroCelect from other ACI treatments is that TiGenix tests the tissue sample taken from the patient for certain genetic markers […]
